Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
Joachim Maus,Kastrup Horst,Istvan Szelenyi,Peter Jurgen Cnota,Bauhofer Artur
申请号：
US13242241
公开号：
US08518918B2
申请日:
2011.09.23
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to novel combinations based on anticholinergics, β2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases.
